Announcement • May 02
ELANTAS Beck India Limited to Report Q4, 2026 Results on May 12, 2026 ELANTAS Beck India Limited announced that they will report Q4, 2026 results on May 12, 2026 New Risk • Apr 24
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 21% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Apr 24
Full year 2025 earnings released: EPS: ₹186 (vs ₹176 in FY 2024) Full year 2025 results: EPS: ₹186 (up from ₹176 in FY 2024). Revenue: ₹8.55b (up 13% from FY 2024). Net income: ₹1.48b (up 5.9% from FY 2024). Profit margin: 17% (down from 19% in FY 2024). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • Apr 18
Dividend of ₹7.50 announced Dividend of ₹7.50 is the same as last year. Ex-date: 5th May 2026 Payment date: 11th June 2026 Dividend yield will be 0.08%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 4%. Cash payout ratio: 6%. Announcement • Apr 16
ELANTAS Beck India Limited, Annual General Meeting, May 12, 2026 ELANTAS Beck India Limited, Annual General Meeting, May 12, 2026, at 10:30 Indian Standard Time. Reported Earnings • Feb 25
Full year 2025 earnings released: EPS: ₹186 (vs ₹176 in FY 2024) Full year 2025 results: EPS: ₹186 (up from ₹176 in FY 2024). Revenue: ₹8.96b (up 19% from FY 2024). Net income: ₹1.48b (up 5.9% from FY 2024). Profit margin: 17% (down from 19% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 24
ELANTAS Beck India Limited Recommends Final Dividend for the Financial Year Ended December 31, 2025 The Board of Directors of ELANTAS Beck India Limited at its meeting held on 24th February, 2026, has, approved and taken on record the following: Recommended a final dividend of INR 7.50/- per fully paid-up equity shares of INR 10/- each (face value) i.e. for the financial year ended 31 st December, 2025, subject to deduction of tax, as applicable and approval of Members at the ensuing seventieth (70th) Annual General Meeting ("AGM"). The Company will inform in due course, the date of seventieth (70th) Annual General Meeting and the date of payment of dividend. Announcement • Feb 02
ELANTAS Beck India Limited to Report Q4, 2025 Results on Feb 24, 2026 ELANTAS Beck India Limited announced that they will report Q4, 2025 results on Feb 24, 2026 Reported Earnings • Nov 05
Third quarter 2025 earnings released: EPS: ₹45.74 (vs ₹39.19 in 3Q 2024) Third quarter 2025 results: EPS: ₹45.74 (up from ₹39.19 in 3Q 2024). Revenue: ₹2.24b (up 22% from 3Q 2024). Net income: ₹362.6m (up 17% from 3Q 2024). Profit margin: 16% (in line with 3Q 2024). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 15
ELANTAS Beck India Limited to Report Q3, 2025 Results on Nov 04, 2025 ELANTAS Beck India Limited announced that they will report Q3, 2025 results on Nov 04, 2025 New Risk • Aug 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (52% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change). Reported Earnings • Aug 06
Second quarter 2025 earnings released: EPS: ₹49.56 (vs ₹52.79 in 2Q 2024) Second quarter 2025 results: EPS: ₹49.56 (down from ₹52.79 in 2Q 2024). Revenue: ₹2.28b (up 19% from 2Q 2024). Net income: ₹392.9m (down 6.1% from 2Q 2024). Profit margin: 17% (down from 22% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹13,393, the stock trades at a trailing P/E ratio of 78.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 229% over the past three years. Upcoming Dividend • Apr 17
Upcoming dividend of ₹7.50 per share Eligible shareholders must have bought the stock before 23 April 2025. Payment date: 29 May 2025. Payout ratio is a comfortable 4.3% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.4%). Lower than average of industry peers (0.7%). Announcement • Apr 11
ELANTAS Beck India Limited to Report Q4, 2025 Results on Apr 30, 2025 ELANTAS Beck India Limited announced that they will report Q4, 2025 results on Apr 30, 2025 Reported Earnings • Apr 11
Full year 2024 earnings released: EPS: ₹176 (vs ₹173 in FY 2023) Full year 2024 results: EPS: ₹176 (up from ₹173 in FY 2023). Revenue: ₹7.55b (up 10% from FY 2023). Net income: ₹1.40b (up 1.7% from FY 2023). Profit margin: 19% (down from 20% in FY 2023). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • Apr 03
Dividend increased to ₹7.50 Dividend of ₹7.50 is 50% higher than last year. Ex-date: 23rd April 2025 Payment date: 29th May 2025 Dividend yield will be 0.08%, which is lower than the industry average of 0.8%. Announcement • Apr 02
ELANTAS Beck India Limited, Annual General Meeting, Apr 30, 2025 ELANTAS Beck India Limited, Annual General Meeting, Apr 30, 2025, at 10:30 Indian Standard Time. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹9,775, the stock trades at a trailing P/E ratio of 55.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 199% over the past three years. Reported Earnings • Feb 19
Full year 2024 earnings released: EPS: ₹176 (vs ₹173 in FY 2023) Full year 2024 results: EPS: ₹176 (up from ₹173 in FY 2023). Revenue: ₹8.03b (up 17% from FY 2023). Net income: ₹1.40b (up 1.7% from FY 2023). Profit margin: 17% (down from 20% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 18
ELANTAS Beck India Limited Recommends Final Dividend for the Financial Year Ended December 31, 2024 ELANTAS Beck India Limited Recommended a final dividend of INR 7.50/- per fully paid-up equity shares of INR 10/- each (face value) for the financial year ended 31st December, 2024, subject to deduction of tax, as applicable and approval of Members at the ensuing sixty-ninth Annual General Meeting . Announcement • Feb 10
ELANTAS Beck India Limited to Report Q3, 2025 Results on Feb 18, 2025 ELANTAS Beck India Limited announced that they will report Q3, 2025 results on Feb 18, 2025 Announcement • Jan 29
Elantas Beck India Limited Announces Resignation of Srikumar Ramakrishnan as Director, Effective from 31 January, 2025 ELANTAS Beck India Limited announced Resignation of Mr. Srikumar Ramakrishnan as Director of the Company, due to a move to another position overseas within ALTANA group, with effect from the close of business hours of 31 January, 2025. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: ₹39.19 (vs ₹43.93 in 3Q 2023) Third quarter 2024 results: EPS: ₹39.19 (down from ₹43.93 in 3Q 2023). Revenue: ₹1.96b (up 20% from 3Q 2023). Net income: ₹310.7m (down 11% from 3Q 2023). Profit margin: 16% (down from 21% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 28
ELANTAS Beck India Limited Appoints Anurag Roy as President ELANTAS Beck India Limited approved appointment of Mr. Anurag Roy, as President (Senior Management Personnel) of the Company with effect from 28th October,2024 on recommendation of Nomination and remuneration committee. Terms of Appointment- Full Time employment. Mr. Anurag Roy, aged 50 years, has over 24 years of experience in the chemicals and life sciences sectors. Mr. Roy has held significant positions at companies such as
Godrej Astec Lifesciences, DSM, Dr. Reddy's Labs, BASF, Jubilant Life Sciences, and Frost & Sullivan. He has a strong track record in managing global businesses, particularly in the Asia Pacific, Middle Eastern & Africa regions, and excels in commercial and operational excellence. Throughout his career, he has established and led multiple manufacturing and supply sites, as well as Technology Centers. Mr. Anurag Roy's professional journey spans continents, including over a decade in the USA, where he held senior leadership positions. He holds an MBA from Columbia Business School in New York, a master's degree in international business from the Indian Institute of Foreign Trade in Delhi, and a bachelor's degree in chemical technology from Harcourt Butler Technological Institute in Kanpur. Announcement • Oct 17
ELANTAS Beck India Limited to Report Q2, 2025 Results on Oct 28, 2024 ELANTAS Beck India Limited announced that they will report Q2, 2025 results on Oct 28, 2024 Reported Earnings • Aug 08
Second quarter 2024 earnings released: EPS: ₹52.79 (vs ₹44.68 in 2Q 2023) Second quarter 2024 results: EPS: ₹52.79 (up from ₹44.68 in 2Q 2023). Revenue: ₹2.08b (up 10% from 2Q 2023). Net income: ₹418.5m (up 18% from 2Q 2023). Profit margin: 20% (up from 19% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹12,671, the stock trades at a trailing P/E ratio of 69.7x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 225% over the past three years. Announcement • Jul 24
ELANTAS Beck India Limited to Report Q1, 2025 Results on Aug 06, 2024 ELANTAS Beck India Limited announced that they will report Q1, 2025 results on Aug 06, 2024 Reported Earnings • May 08
First quarter 2024 earnings released: EPS: ₹46.56 (vs ₹41.30 in 1Q 2023) First quarter 2024 results: EPS: ₹46.56 (up from ₹41.30 in 1Q 2023). Revenue: ₹1.92b (up 12% from 1Q 2023). Net income: ₹369.1m (up 13% from 1Q 2023). Profit margin: 19% (in line with 1Q 2023). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Apr 24
Upcoming dividend of ₹5.00 per share Eligible shareholders must have bought the stock before 30 April 2024. Payment date: 05 June 2024. Payout ratio is a comfortable 2.9% and this is well supported by cash flows. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.8%). New Risk • Apr 16
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Declared Dividend • Apr 10
Dividend of ₹5.00 announced Dividend of ₹5.00 is the same as last year. Ex-date: 30th April 2024 Payment date: 5th June 2024 Dividend yield will be 0.06%, which is lower than the industry average of 0.8%. Payout Ratios Payout ratio: 3%. Cash payout ratio: 3%. Announcement • Apr 09
ELANTAS Beck India Limited, Annual General Meeting, May 07, 2024 ELANTAS Beck India Limited, Annual General Meeting, May 07, 2024, at 10:30 Indian Standard Time. Reported Earnings • Feb 21
Full year 2023 earnings released: EPS: ₹173 (vs ₹123 in FY 2022) Full year 2023 results: EPS: ₹173 (up from ₹123 in FY 2022). Revenue: ₹6.80b (up 5.4% from FY 2022). Net income: ₹1.37b (up 40% from FY 2022). Profit margin: 20% (up from 15% in FY 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 03
ELANTAS Beck India Limited to Report Q3, 2024 Results on Feb 20, 2024 ELANTAS Beck India Limited announced that they will report Q3, 2024 results on Feb 20, 2024 Announcement • Jan 16
Elantas Beck India Limited Appoints Ashutosh B. Kulkarni as Head-Legal (Senior Management Personnel) ELANTAS Beck India Limited informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company on 15 January 2024 has approved the appointment of Mr. Ashutosh B. Kulkarni as Head-Legal (Senior Management Personnel) of the Company with effect from 15 January 2024. Terms of Appointment- Full Time employment.Mr. Ashutosh B. Kulkarni is an Associate Member (ACS No- 18549) ofThe Institute of Company Secretaries of India and having academic qualifications of Bachelor of Commerce (B.Com) and Bachelor of Laws (LLB) from Pune University. He is enriched with 19 years ovaried experience in the domain of Company Secretarial Functions,Legal Affairs, Finance, M&A,Statutory Compliances & Corporate Governance and has worked with large reputed companies. Announcement • Jan 02
ELANTAS Beck India Limited Announces Resignation of Abhijit Tikekar as Company Secretary and Compliance Officer ELANTAS Beck India Limited has announced resignation of Abhijit Tikekar as Company Secretary and Compliance Officer, with effect from the close of business hours on December 31, 2023. Announcement • Nov 08
ELANTAS Beck India Limited Announces the Resignation of Abhijit Tikekar as Company Secretary & Compliance Officer, Effective 31 December 2023 ELANTAS Beck India Limited at its board meeting held on 7 November, 2023, noted resignation of Mr. Abhijit Tikekar as Company Secretary & Compliance Officer (KMP), with effect from 31 December 2023. Mr. Abhijit Tikekar has been associated with the Company since September 2018 and he wishes to pursue career opportunities overseas. Reported Earnings • Nov 08
Third quarter 2023 earnings released: EPS: ₹43.93 (vs ₹34.07 in 3Q 2022) Third quarter 2023 results: EPS: ₹43.93 (up from ₹34.07 in 3Q 2022). Revenue: ₹1.75b (up 14% from 3Q 2022). Net income: ₹348.3m (up 29% from 3Q 2022). Profit margin: 20% (up from 18% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 26
ELANTAS Beck India Limited to Report Q2, 2024 Results on Nov 07, 2023 ELANTAS Beck India Limited announced that they will report Q2, 2024 results on Nov 07, 2023 Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹8,043, the stock trades at a trailing P/E ratio of 53.6x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 239% over the past three years. Reported Earnings • Aug 03
Second quarter 2023 earnings released: EPS: ₹44.68 (vs ₹25.95 in 2Q 2022) Second quarter 2023 results: EPS: ₹44.68 (up from ₹25.95 in 2Q 2022). Revenue: ₹1.73b (up 1.4% from 2Q 2022). Net income: ₹354.2m (up 72% from 2Q 2022). Profit margin: 20% (up from 12% in 2Q 2022). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jun 22
Elantas Beck India Limited Announces Appointment of Sujjain Talwar as Additional Director and Also Non-Executive & Independent Director, Effective 22 June 2023 ELANTAS Beck India Limited announced at the board meeting held on June 21, 2023 that the company approved, appointed Mr. Sujjain Talwar as Additional Director and also, Non-Executive & Independent Director for a period of 5 (five) years with effect from 22 June 2023. Mr. Sujjain Talwar, aged 59 years, has over 30 years of experience in corporate, infrastructure, hospitality and banking bt finance laws. Mr. Sujjain Talwar is a co-founding Partner of Economic Laws Practice (ELP) a leading Tier 1 full-service law firm in India. Mr. Sujjain Talwar has worked extensively on private sector participation initiatives in various infrastructure projects in India and abroad. His work includes infrastructure projects in the region, including Yemen, Fujairah, Djibouti and the Maldives. He has international experience in managing public- private participation across various infrastructure sectors including water, roads, ports and airports. Mr. Sujjain Talwar holds a graduate degree in Commerce, University of Bombay, LL. B, Government Law College, Qualified as a Solicitorin India and was a gold medalist in the Solicitor's Examinations and Qualified as Solicitor, England and Wales. Announcement • May 11
Elantas Beck India Limited Announces Stepping Down of Mr. Suresh Talwar Non-Executive & Independent Director This is to inform that the Board of Directors, at its Meeting held on 9 May, 2023, noted stepping down of Mr. Suresh Talwar Non-Executive & Independent Director of ELANTAS Beck India Limited from the Directorship of the Company with effect from the close of business hours on 9 May 2023. Valuation Update With 7 Day Price Move • May 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹6,095, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 167% over the past three years. Upcoming Dividend • Apr 25
Upcoming dividend of ₹5.00 per share at 0.1% yield Eligible shareholders must have bought the stock before 02 May 2023. Payment date: 07 June 2023. Payout ratio is a comfortable 4.1% and this is well supported by cash flows. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%). Reported Earnings • Apr 19
Full year 2022 earnings released Full year 2022 results: Net income: ₹977.8m (up 46% from FY 2021). Reported Earnings • Feb 22
Full year 2022 earnings released: EPS: ₹123 (vs ₹84.37 in FY 2021) Full year 2022 results: EPS: ₹123 (up from ₹84.37 in FY 2021). Revenue: ₹6.62b (up 27% from FY 2021). Net income: ₹977.8m (up 46% from FY 2021). Profit margin: 15% (up from 13% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year. Announcement • Feb 02
ELANTAS Beck India Limited to Report Q3, 2023 Results on Feb 21, 2023 ELANTAS Beck India Limited announced that they will report Q3, 2023 results on Feb 21, 2023 Board Change • Nov 16
High number of new directors Additional Non-Executive & Non-Independent Director Ravindra Kumar was the last director to join the board, commencing their role in 2022. Board Change • Nov 03
High number of new directors Additional Non-Executive & Non-Independent Director Ravindra Kumar was the last director to join the board, commencing their role in the last week. Reported Earnings • Nov 02
Third quarter 2022 earnings released: EPS: ₹34.07 (vs ₹24.70 in 3Q 2021) Third quarter 2022 results: EPS: ₹34.07 (up from ₹24.70 in 3Q 2021). Revenue: ₹1.58b (up 19% from 3Q 2021). Net income: ₹270.1m (up 38% from 3Q 2021). Profit margin: 17% (up from 15% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year and the company’s share price has also increased by 20% per year. Announcement • Nov 02
ELANTAS Beck India Limited Announces Directorate Changes ELANTAS Beck India Limited announced appointment of Mr. Ravindra Kumar (DIN: 06755402) as Additional Director and further, as a Non-Executive & Non - Independent Director with effect from 2 November 2022 subject to the approval of Shareholders effective 2 November 2022 in place of Mr. Ravindra Kulkarni (DIN: 00059367), as he steps down as Non-Executive & Independent Director from the Directorship of the Company with effect from the close of business hours on 1 November 2022. Mr. Ravindra Kumar is Bachelor of Chemical Technology (Oil Tech) from HBTI, Kanpur. He has also obtained post- graduate degree in `Competitive Marketing Strategy' from the Indian Institute of Management (IIM), Bangalore. He has more than 26 years of experience and has worked on various projects in the areas of sales & marketing, new business development, new product development, inventory management, key account management, fixed cost management, resource planning, HR operations, supply chain, finance 8 investment related activities He does not hold Directorships/Committe e Membership of any other companies in India. Announcement • Oct 18
ELANTAS Beck India Limited to Report Q3, 2022 Results on Nov 01, 2022 ELANTAS Beck India Limited announced that they will report Q3, 2022 results on Nov 01, 2022 Reported Earnings • Jul 28
Second quarter 2022 earnings released: EPS: ₹25.95 (vs ₹15.87 in 2Q 2021) Second quarter 2022 results: EPS: ₹25.95 (up from ₹15.87 in 2Q 2021). Revenue: ₹1.71b (up 49% from 2Q 2021). Net income: ₹205.7m (up 64% from 2Q 2021). Profit margin: 12% (up from 11% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jul 28
Elantas Beck India Limited Announces Resignation of Kishori Udeshi as Non-Executive and Independent Director from the Directorship of the Company ELANTAS Beck India Limited informed that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors, at its Meeting held on 27 July, 2022, noted stepping down of Mrs. Kishori Udeshi (DIN: 01344073), Non-Executive and Independent Director from the Directorship of the Company with effect from 27 July 2022. Reported Earnings • Apr 17
Full year 2021 earnings released: EPS: ₹84.37 (vs ₹77.91 in FY 2020) Full year 2021 results: EPS: ₹84.37 (up from ₹77.91 in FY 2020). Revenue: ₹5.22b (up 36% from FY 2020). Net income: ₹668.8m (up 8.3% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 16% per year. Announcement • Apr 14
ELANTAS Beck India Limited to Report Q1, 2022 Results on May 10, 2022 ELANTAS Beck India Limited announced that they will report Q1, 2022 results on May 10, 2022 Announcement • Apr 13
ELANTAS Beck India Limited Recommends Payment of Dividend, Payable on or After June 6, 2022 ELANTAS Beck India Limited at its board meeting held on 22 February 2022 recommended payment of dividend of INR 5.00/- per equity share of INR 10/-each, for the year 2021 Payable on or after June 6, 2022. Reported Earnings • Feb 25
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₹84.36 (up from ₹77.91 in FY 2020). Revenue: ₹5.22b (up 36% from FY 2020). Net income: ₹668.8m (up 8.3% from FY 2020). Profit margin: 13% (down from 16% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 15% per year. Announcement • Feb 24
ELANTAS Beck India Limited Recommends Payment of Dividend for the Year 2021 ELANTAS Beck India Limited at its board meeting held on 22 February 2022 recommended payment of dividend of INR 5.00/- per equity share of INR 10/-each, for the year 2021. Announcement • Feb 08
ELANTAS Beck India Limited to Report Fiscal Year 2021 Results on Feb 22, 2022 ELANTAS Beck India Limited announced that they will report fiscal year 2021 results on Feb 22, 2022 Reported Earnings • Nov 07
Third quarter 2021 earnings released: EPS ₹24.70 (vs ₹26.69 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: ₹1.38b (up 21% from 3Q 2020). Net income: ₹195.8m (down 7.5% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jul 28
Second quarter 2021 earnings released: EPS ₹15.87 (vs ₹5.99 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹1.19b (up 121% from 2Q 2020). Net income: ₹125.8m (up 165% from 2Q 2020). Profit margin: 11% (up from 8.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Board Change • Jul 28
High number of new directors Additional Non-Executive & Independent Director Nandkumar Vasant Dhekne was the last director to join the board, commencing their role in 2021. Announcement • May 05
ELANTAS Beck India Limited Approves the Declaration of Dividend for the Year 2020 ELANTAS Beck India Limited approved the declaration of dividend on equity shares for the year 2020 that is INR 5.00 per equity share of INR 10 each. Valuation Update With 7 Day Price Move • Mar 02
Investor sentiment improved over the past week After last week's 33% share price gain to ₹3,800, the stock is trading at a trailing P/E ratio of 48.8x, up from the previous P/E ratio of 36.6x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 91%. Is New 90 Day High Low • Mar 01
New 90-day high: ₹3,345 The company is up 32% from its price of ₹2,536 on 01 December 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Reported Earnings • Feb 25
Full year 2020 earnings released: EPS ₹77.91 (vs ₹62.52 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₹3.83b (down 2.8% from FY 2019). Net income: ₹617.6m (up 25% from FY 2019). Profit margin: 16% (up from 13% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings. Announcement • Feb 02
ELANTAS Beck India Limited to Report Q4, 2020 Results on Feb 23, 2021 ELANTAS Beck India Limited announced that they will report Q4, 2020 results on Feb 23, 2021 Is New 90 Day High Low • Jan 01
New 90-day high: ₹2,807 The company is up 9.0% from its price of ₹2,586 on 01 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: ₹2,708 The company is up 5.0% from its price of ₹2,575 on 15 September 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. Reported Earnings • Nov 04
Third quarter 2020 earnings released: EPS ₹26.69 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₹1.17b (up 23% from 3Q 2019). Net income: ₹211.6m (up 49% from 3Q 2019). Profit margin: 18% (up from 15% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Announcement • Oct 13
ELANTAS Beck India Limited to Report Q3, 2020 Results on Nov 03, 2020 ELANTAS Beck India Limited announced that they will report Q3, 2020 results on Nov 03, 2020 Is New 90 Day High Low • Sep 18
New 90-day high: ₹2,628 The company is up 13% from its price of ₹2,327 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Announcement • Jul 17
ELANTAS Beck India Limited to Report Q2, 2020 Results on Jul 28, 2020 ELANTAS Beck India Limited announced that they will report Q2, 2020 results on Jul 28, 2020 
